Αvβ3 Integrin-Targeted Micellar Mertansine Prodrug Effectively Inhibits Triple-Negative Breast Cancer in Vivo

International Journal of Nanomedicine - New Zealand
doi 10.2147/ijn.s146505
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Targeted Therapies in Triple-Negative Breast Cancer: Failure and Future

Women's Health
Medicine
2015English

Triple-Negative Breast Cancer

2018English

Antiintegrin Alpha v Beta 3 Blocks Human Breast Cancer Growth and Angiogenesis in Human Skin.

Journal of Clinical Investigation
Medicine
1995English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2018English

Alpha-V Integrin Targeted PET Imaging of Breast Cancer Angiogenesis and Low-Dose Metronomic Anti-Angiogenic Chemotherapy Efficacy

2007English

Targeted Exosomes‐encapsulated Erastin Induced Ferroptosis in the Triple Negative Breast Cancer Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

FZD7 in Triple Negative Breast Cancer Cells

2011English

In Vitro Antineoplastic Activity in Triple-Negative Breast Cancer Cell Line and in Vivo

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy